GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

Recruiting now · Not applicable

Conditions studied: Major Neurocognitive Disorder

In brief

The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life and autonomy. The intervention will include knowledge exchange sessions with nurses, pharmacists, and doctors in FMGs, and increased collaboration between these professionals and home care services teams. Other goal is to increase the satisfaction of the seniors, their families, and the professionals involved in the GPS project.

Key facts

Study ID

NCT04889794

Run by

CHU de Quebec-Universite Laval

People needed

400

Starts

2021-09-27

Expected to finish

2026-12-01

Last updated by the study team

2024-08-22

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All seniors (65 years of age or older) undergoing cognitive evaluation OR referred to a memory clinic OR having been diagnosed with cognitive impairment within the last year OR with MCND and followed up at home AND,
• referred to the pharmacist, for the FMGs exposed
• taking prescription medications

You may not qualify if…

• Seniors in palliative care OR
• unable to answer questionnaires in French AND without a caregiver.

Where it is running

• GMF Bordeaux-Cartierville — Montreal, Quebec, Canada (enrolling)
• GMF Abénakis — Saint-Georges, Quebec, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.